Form 4: Pacira BioSciences CFO Charles A. Reinhart III Reports Acquisition of Restricted Stock Units

Charles A. Reinhart III, CFO of Pacira BioSciences, reports the acquisition of 12,220 restricted stock units on June 12, 2024.

Summary

• On June 12, 2024, Charles A. Reinhart III, the Chief Financial Officer of Pacira BioSciences, acquired 12,220 restricted stock units.
• These restricted stock units vest on June 12, 2025, contingent upon Reinhart's continuous service with the company.
• Each restricted stock unit represents the right to receive one share of Pacira BioSciences' common stock.
• Following the transaction, Reinhart directly owns 51,867 shares of Pacira BioSciences common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of restricted stock units by the CFO is a common practice and suggests confidence in the company's future performance. However, it's a routine filing and doesn't necessarily indicate a major shift in the company's prospects.

Positives

• The acquisition of restricted stock units aligns the CFO's interests with the long-term success of Pacira BioSciences.
• The vesting requirement of continuous service encourages the CFO's continued commitment to the company.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• The acquisition of restricted stock units aligns the CFO's interests with those of the shareholders, potentially leading to decisions that benefit the company's long-term value.

Key Dates